News | December 20, 2022
Guerison to set up footprints in India’s ophthalmology market
Global pharmaceutical company having a surgical business concept incepted in Dubai
Global pharmaceutical company having a surgical business concept incepted in Dubai
Positive opinions based on significant survival benefit
Ayúdame3D has become a leading social entity in social technology.
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The current ruling will assure the safety of the use of Ranitidine for Indian patients
EC grants conditional marketing authorization based on the EFFISAYIL trial
The hospital is being developed at a cost of more than Rs. 1,575 crore
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
Soluplus branded excipient play a critical role in enabling the drug development process for poorly soluble active pharmaceutical ingredients
Subscribe To Our Newsletter & Stay Updated
